158P: PET/CT based imaging biomarkers for response prediction of stage IV NSCLC treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin

E E C de Jong; W Van Elmpt; R T H Leijenaar; Harry J M Groen; E Smit; R Boellaard; V Van der Noort; E G C Troost; P Lambin; A-M Dingemans

doi:10.1016/S1556-0864(16)30268-4

158P: PET/CT based imaging biomarkers for response prediction of stage IV NSCLC treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin

E E C de Jong
, W Van Elmpt
, R T H Leijenaar
, Harry J M Groen
, E Smit
, R Boellaard
, V Van der Noort
, E G C Troost
, P Lambin
, A-M Dingemans

Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE)

Research output: Contribution to journal › Article › Academic › peer-review

19 Downloads (Pure)

Original language	English
Pages (from-to)	S126-S127
Journal	Journal of Thoracic Oncology
Volume	11
Issue number	4 Supplement
DOIs	https://doi.org/10.1016/S1556-0864(16)30268-4
Publication status	Published - Apr-2016

Access to Document

10.1016/S1556-0864(16)30268-4Licence: Unspecified

Handle.net

Persistent link

Embargoed Document

PETCT based imaging biomarkers for response prediction
Final publisher's version, 78.4 KB

Cite this

Jong, E. E. C. D., Van Elmpt, W., Leijenaar, R. T. H., Groen, H. J. M., Smit, E., Boellaard, R., Noort, V. V. D., Troost, E. G. C., Lambin, P., & Dingemans, A.-M. (2016). 158P: PET/CT based imaging biomarkers for response prediction of stage IV NSCLC treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin. Journal of Thoracic Oncology, 11(4 Supplement), S126-S127. https://doi.org/10.1016/S1556-0864(16)30268-4

@article{553b2c0afebf4feb861f75790ee99aef,

title = "158P: PET/CT based imaging biomarkers for response prediction of stage IV NSCLC treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin",

author = "Jong, \{E E C de\} and \{Van Elmpt\}, W and Leijenaar, \{R T H\} and Groen, \{Harry J M\} and E Smit and R Boellaard and Noort, \{V Van der\} and Troost, \{E G C\} and P Lambin and A-M Dingemans",

year = "2016",

month = apr,

doi = "10.1016/S1556-0864(16)30268-4",

language = "English",

volume = "11",

pages = "S126--S127",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "ELSEVIER SCIENCE INC",

number = "4 Supplement",

}

Jong, EECD, Van Elmpt, W, Leijenaar, RTH, Groen, HJM, Smit, E, Boellaard, R, Noort, VVD, Troost, EGC, Lambin, P & Dingemans, A-M 2016, '158P: PET/CT based imaging biomarkers for response prediction of stage IV NSCLC treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin', Journal of Thoracic Oncology, vol. 11, no. 4 Supplement, pp. S126-S127. https://doi.org/10.1016/S1556-0864(16)30268-4

158P: PET/CT based imaging biomarkers for response prediction of stage IV NSCLC treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin. / Jong, E E C de; Van Elmpt, W; Leijenaar, R T H et al.
In: Journal of Thoracic Oncology, Vol. 11, No. 4 Supplement, 04.2016, p. S126-S127.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - 158P

T2 - PET/CT based imaging biomarkers for response prediction of stage IV NSCLC treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin

AU - Jong, E E C de

AU - Van Elmpt, W

AU - Leijenaar, R T H

AU - Groen, Harry J M

AU - Smit, E

AU - Boellaard, R

AU - Noort, V Van der

AU - Troost, E G C

AU - Lambin, P

AU - Dingemans, A-M

PY - 2016/4

Y1 - 2016/4

U2 - 10.1016/S1556-0864(16)30268-4

DO - 10.1016/S1556-0864(16)30268-4

M3 - Article

C2 - 27198295

SN - 1556-0864

VL - 11

SP - S126-S127

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 4 Supplement

ER -